Successful strategies for increasing African American participation in cancer genetic studies: Hopeful signs for equalizing the benefits of genetic medicine

Community Genetics

Volumn 11, Issue 4, 2008, Pages 208-214

  Patterson, Annette R ^a   Davis, Helen ^a   Shelby, Kristin ^a   McCoy, Jerry ^a   Robinson, Linda D ^a   Rao, Smita K ^a   Banerji, Pia ^a   Tomlinson, Gail E ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

African American; Cancer genetic studies; Hereditary breast cancer; Minority recruitment

Indexed keywords

ADVERTIZING; AFRICAN AMERICAN; ARTICLE; CANCER CENTER; CANCER GENETICS; CANCER REGISTRY; CANCER RESEARCH; COMPARATIVE STUDY; EUROPEAN AMERICAN; FEMALE; GENETIC COUNSELING; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

AFRICAN AMERICANS; BIOMEDICAL RESEARCH; GENETIC RESEARCH; HUMANS; MASS SCREENING; NEOPLASMS; PATIENT PARTICIPATION; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 42349096703     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116881     Document Type: Article

References (32)

1. US Census Bureau: Quick Facts from the US Census Bureau. http://quickfacts.census.gov/qfd/states/48/48113/html, accessed 6/20/2007.
2. Royal C, Baffoe-Bonnie A, Kittles R, Powell I, Bennett J, Hoke G, Pettaway MD, Weinrich S, Vijayakumar S, Ahaghotu C, Mason T, Johnson E, Obeikwe M, Simpson C, Jejia R, Boykin W, Roberson P, Frost J, Faison-Smith L, Meegan C, Foster N, Furbert-Harris P, Carpten J, Bailey-Wilson J, Trent J, Berg K, Dunston G, Collins F: Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) Study. Ann Epidemiol 2000;10:S68-S77.
3. Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald PG, Skinner CS, Bowen D: Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 2004;13:1146-1155.
4. Patterson AR, Davis H, Euhus D, Neuhausen S, Strong L, Tomlinson GE: Recruitment for breast cancer predisposition studies in an underserved African American population. Breast J 2005;11:79-82.
5. McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM: Increasing minority participation in cancer clinical trials: The Minority-Based Community Clinical Oncology Program experience. J Clin Oncol 2005;23:5247-5254.
6. Lee RE, McGinnis KA, Sallis JF, Castro CM, Chen AH, Hickmann SA: Active vs. passive methods of recruiting ethnic minority women to a health promotion program. Ann Behav Med 1997;19:378-384.
7. National Cancer Institute website for Cancer Control and Population Sciences: Epidemiology and Genetics Research; Cancer Genetics Network. http://epi.grants.cancer.gov/CGN/, accessed 9/11/2005.
8. Texas Cancer Genetics Consortium: Buena Vida: A Guide to Family Cancer Research. http://texas.cgnweb.org.
9. Steiglitz H: What's in Your Family Tree? San Antonio, University of Texas Southwestern Medical Center, 1995.
10. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM: Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998;29:787-796.
11. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Barber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL: Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1442-1443.
12. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hemsley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K: Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-1615.
13. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Issacs C, Daly MB, Matloff E, Olopade OI, Weber BL, Prevention and Observation of Surgical End Points Study Group: prophylactic ophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-1622.
14. Olopade OI: Genetics in clinical cancer care: a promise unfulfilled among minority populations. Can Epidemiol Biomarkers Prev 2004;13:1683-1686.
15. Pal T, Permuth-Wey J, Holtje T, Sutphen R: BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Can Epidemiol Biomarkers Prev 2004;13:1794-1799.
16. Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD: Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 2002;11:79-87.
17. Thompson HS, Valdimarsdottir HB, Dutear-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda R, Amarel D, Godfrey D, Brown K, Offit K: Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 2002;11:1579-1585.
18. Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Issacs C, Barter J, Lerman C: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32:51-62.
19. Donovan KA, Tucker DC: Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med 2000;23:15-35.
20. Phillips JM, Cohen MZ, Moses G: Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum 1999;26:561-571.
21. Cancer Facts and Figures 2001. Atlanta, American Cancer Society, 2001. 22 Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM: Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 2004;13:1349-1354.
22. Benkendorf JL, Reutenauer JE, Hughes CA, et al: Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet 1997;73:296-303.
23. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J: Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361-367.
24. Matthews AK, Cummings S, Thompson S, Wolh V, List M, Olopade O: Genetic testing of African Americans for susceptibility to inherited cancers: use of focus groups to determine factors contributing to participation. J Psychosoc Oncol 2000;18:1-19.
25. Hughes C, Fasaye GA, LaSalle VH, Finch C: Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 2003;51:107-114.
26. Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL: Knowledge, attitudes and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med 2001;33:543-551.
27. Fouad MN, Partridge E, Green BL, Kohler C, Wynn T, Nagy S, Churchill S: Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol 2000;10:S35-S40.
28. Swanson GM, Ward AJ: Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Can Inst 1995;87:1747-1759.
29. Brown BA, Long HL, Gould H, Weitz T, Milliken N: A conceptual model for the recruitment of diverse women into research studies. J Womens Health Gend Based Med 2002;9:625-632.
30. Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP: Participation rates in a case-control study: the impact of age, race and race of interviewer. Ann Epidemiol 1999;9:188-195.
31. Abrums M: 'Jesus will fix it after awhile': meanings and health. Soc Sci Med 2000;50:89-105.
32. Gamble VN: Under the shadow of Tuskegee: African Americans and health care. Am J Public Health 1997;87:1773-1778.